RxSight (RXST) Reiterated at Neutral by UBS: 'Need More Regular Signs of Come-back'
Tweet Send to a Friend
UBS analyst Danielle Antalffy reiterated a Neutral rating and $8.00 price target on RxSight Inc. (NASDAQ: RXST).The analyst commented, "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
